Related Experiment Video
Updated: Mar 19, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
A eureka moment - using coalface data for discovery on TB disease and financial relief
K Watts1,2, K Dale1,3, J T Denholm1,4
1Victorian Tuberculosis Program, Royal Melbourne Hospital, Melbourne, Australia.
Background:
Although Australia maintains a low incidence of TB, elimination remains elusive. To support program delivery and evaluation, intervention fidelity, trends and patterns in the provision of financial relief were explored. Insights for practitioners and funders inform decision-making.
Methods:
Data and process mining approaches were used to explore the dispersal of vouchers and small grants processed through the Victorian Tuberculosis Program. Data sources identified, curated, and analysed included financial relief dispersal records and public health documentation (sociodemographic, TB, and health care access characteristics). Queries and analysis were shaped through practitioner consultation.
Results:
Of 3,811 TB events, 15% received financial relief during treatment. Relief recipients were younger, more often male, and more likely to have pulmonary disease and cavitation. Twice as likely to be part of whole genome sequencing-defined transmission clusters, recipients also experienced more treatment interruptions. Practitioner insights revealed that financial relief functioned as a response to hardship and as an enabler or incentive to support engagement with care.
Conclusion:
The observed patterns and trends suggest an intersection between TB vulnerability and financial relief. Low-incidence, high-income settings likely benefit from financial relief to mitigate structural inequities. Further research should detail the nature of financial hardship, co-occurring indicators of TB, and their proximity to TB care outcomes.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Other Pulmonary Disorders

